Literature DB >> 28455679

Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over.

Donna H Ryan1, Sarah Ryan Yockey2.   

Abstract

PURPOSE OF REVIEW: One begins to see improvement in glycemic measures and triglycerides with small amounts of weight loss, but with greater levels of weight loss there is even greater improvement. In fact, the relationship between weight loss and glycemia is one that is very close. RECENT
FINDINGS: This is fortunate for diabetes prevention; it takes only small amounts of weight loss to prevent progression to type 2 diabetes from impaired glucose tolerance, and after the 10 kg of weight loss, one cannot demonstrate much additional improvement in risk reduction. Modest weight loss (5 to 10%) is also associated with improvement in systolic and diastolic blood pressure and HDL cholesterol. With all these risk factors, more weight loss produces more improvement. Further, for patients with higher BMI levels (>40 kg/m2), the ability to lose the same proportion of weight with lifestyle intervention is equal to that of those with lower BMI levels, and there is equal benefit in terms of risk factor improvement with modest weight loss. For some comorbid conditions, more weight loss is needed-10 to 15%-to translate into clinical improvement. This is true with obstructive sleep apnea and non-alcoholic steatotic hepatitis. There is a graded improvement in improvements in measures of quality of life, depression, mobility, sexual dysfunction, and urinary stress incontinence, whereby improvements are demonstrable with modest weight loss (5-10%) and with further weight loss there are further improvements. For polycystic ovarian syndrome and infertility, modest weight loss (beginning at 2-5%) can bring improvements in menstrual irregularities and fertility. Moderate weight loss (5-10%) has been shown to be associated with reduced health care costs. Reduction in mortality may take more than 10% weight loss, although definitive studies have not been done to demonstrate that weight loss per se is associated with mortality reduction. Clinicians in medical weight management should bear in mind that the target should be health improvement rather than a number on the scale. The individual patient's targeted health goal should be assessed for response rather than a prescribed percentage weight loss.

Entities:  

Keywords:  Dysglycemia; Dyslipidemia; Hypertension; Infertility; Non-alcoholic fatty liver disease; Obesity; Obesity comorbidity; Obstructive sleep apnea; Polycystic ovarian syndrome; Type 2 diabetes; Weight loss; Weight loss and comorbidity improvement; Weight management

Mesh:

Substances:

Year:  2017        PMID: 28455679      PMCID: PMC5497590          DOI: 10.1007/s13679-017-0262-y

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  36 in total

1.  One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study.

Authors:  Lucy F Faulconbridge; Thomas A Wadden; Richard R Rubin; Rena R Wing; Michael P Walkup; Anthony N Fabricatore; Mace Coday; Brent Van Dorsten; David L Mount; Linda J Ewing
Journal:  Obesity (Silver Spring)       Date:  2011-10-20       Impact factor: 5.002

2.  Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial.

Authors:  Suzanne Phelan; Alka M Kanaya; Leslee L Subak; Patricia E Hogan; Mark A Espeland; Rena R Wing; Kathryn L Burgio; Vicki DiLillo; Amy A Gorin; Delia S West; Jeanette S Brown
Journal:  J Urol       Date:  2012-01-20       Impact factor: 7.450

3.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Authors:  Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski
Journal:  N Engl J Med       Date:  2013-06-24       Impact factor: 91.245

4.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

5.  Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial.

Authors:  Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson
Journal:  Arthritis Rheum       Date:  2004-05

6.  Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes.

Authors:  Samuel T Kuna; David M Reboussin; Kelley E Borradaile; Mark H Sanders; Richard P Millman; Gary Zammit; Anne B Newman; Thomas A Wadden; John M Jakicic; Rena R Wing; F Xavier Pi-Sunyer; Gary D Foster
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

7.  Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial.

Authors:  Benjamin N Breyer; Suzanne Phelan; Patricia E Hogan; Raymond C Rosen; Abbas E Kitabchi; Rena R Wing; Jeanette S Brown
Journal:  J Urol       Date:  2014-02-14       Impact factor: 7.450

8.  Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.

Authors:  Rena R Wing; Wei Lang; Thomas A Wadden; Monika Safford; William C Knowler; Alain G Bertoni; James O Hill; Frederick L Brancati; Anne Peters; Lynne Wagenknecht
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

9.  Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study.

Authors:  Rena R Wing; Dale S Bond; Isaias Noel Gendrano; Thomas Wadden; Judy Bahnson; Cora E Lewis; Frederick Brancati; Stephen Schneider; Abbas E Kitabchi; Brent Van Dorsten; Raymond C Rosen
Journal:  Diabetes Care       Date:  2013-06-11       Impact factor: 19.112

10.  Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes.

Authors:  Donald A Williamson; Jack Rejeski; Wei Lang; Brent Van Dorsten; Anthony N Fabricatore; Katie Toledo
Journal:  Arch Intern Med       Date:  2009-01-26
View more
  97 in total

1.  Loss of Uncoupling Protein 3 Attenuates Western Diet-Induced Obesity, Systemic Inflammation, and Insulin Resistance in Rats.

Authors:  Tyler M Lomax; Sadia Ashraf; Gizem Yilmaz; Romain Harmancey
Journal:  Obesity (Silver Spring)       Date:  2020-07-27       Impact factor: 5.002

Review 2.  Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation.

Authors:  Jocelyn L Bowden; David J Hunter; Leticia A Deveza; Vicky Duong; Krysia S Dziedzic; Kelli D Allen; Ping-Keung Chan; Jillian P Eyles
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

3.  Energy Balance and Weight Loss for Diabetes Remission.

Authors:  Donna H Ryan
Journal:  Diabetes Spectr       Date:  2020-05

4.  Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.

Authors:  Sean P Heffron; Bing-Xue Lin; Manish Parikh; Bianca Scolaro; Steven J Adelman; Heidi L Collins; Jeffrey S Berger; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

5.  Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis.

Authors:  Xiaochen Zhang; Jennifer Rhoades; Bette J Caan; David E Cohn; Ritu Salani; Sabrena Noria; Adrian A Suarez; Electra D Paskett; Ashley S Felix
Journal:  Int J Gynecol Cancer       Date:  2019-08-26       Impact factor: 3.437

6.  Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis.

Authors:  Apostolos Perelas; Jessica Glennie; Karen van Kerkhove; Manshi Li; Rachel G Scheraga; Mitchell A Olman; Daniel A Culver
Journal:  Pulm Pharmacol Ther       Date:  2019-09-10       Impact factor: 3.410

Review 7.  Time-Restricted Eating to Improve Cardiovascular Health.

Authors:  Kelsey Gabel; Sofia Cienfuegos; Faiza Kalam; Mark Ezpeleta; Krista A Varady
Journal:  Curr Atheroscler Rep       Date:  2021-03-26       Impact factor: 5.113

8.  Does the built environment influence the effectiveness of behavioral weight management interventions?

Authors:  Shannon N Zenk; Elizabeth Tarlov; Coady Wing; Sandy Slater; Kelly K Jones; Marian Fitzgibbon; Lisa M Powell
Journal:  Prev Med       Date:  2019-07-19       Impact factor: 4.018

9.  Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults.

Authors:  Liping Lu; Cheng Chen; Kefeng Yang; Jie Zhu; Pengcheng Xun; James M Shikany; Ka He
Journal:  Eur J Nutr       Date:  2020-02-24       Impact factor: 5.614

10.  The Impact of Bariatric Surgery on Incident Microvascular Complications in Patients With Type 2 Diabetes: A Matched Controlled Population-Based Retrospective Cohort Study.

Authors:  Pushpa Singh; Nicola Adderley; Anuradhaa Subramanian; Krishna Gokhale; Rishi Singhal; Konstantinos A Toulis; Srikanth Bellary; Krishnarajah Nirantharakumar; Abd A Tahrani
Journal:  Diabetes Care       Date:  2020-11-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.